Search

Dr. Bollard is an internationally recognized leader in the fields of immunology and immunotherapy. She also serves as director of the Center for Cancer and Immunology Research at the Children’s Research Institute at Children’s National Health System and as a professor of pediatrics and microbiology…

The George Washington University (GW) Cancer Center recently co-hosted a workshop on Improving the Health of the LGBTQ+ Community: Advocating for Ourselves Together at Metropolitan Community Church in D.C.

Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.

A study led by Paul Brindley, PhD, is looking at the cellular link between liver fluke and cholangiocarcinoma.

Katherine Chiappinelli, PhD, was awarded a prestigious grant from The G. Harold and Leila Y. Mathers Foundation.

A team at the GW Cancer Center will study the role of the COMPASS complex in the initiation and progression of pancreatic cancer.

September is Prostate Cancer Awareness Month, also known as National Prostate Health Month, an annual opportunity to raise awareness of the disease and identify funding resources for research into its cause, prevention, diagnosis, treatment, survivorship and cure as well as to support those affec

WASHINGTON (July 27, 2018) -- The George Washington University Hospital (GW Hospital), in conjunction with The GW Cancer Center, has been named a Screening Center of Excellence by the Lung Cancer Alliance (LCA) for its ongoing commitment to responsible lung cancer screening.

Steven A. Rosenberg, MD, received the 2018 Jacobson Innovation Award from the American College of Surgeons for his work in immunotherapies for patients with advanced cancer.

Advances in cancer genetic testing have improved clinical follow-up care for patients at risk for hereditary cancer.